Risk calculations guiding lipid-lowering therapy are given an overhaul in new guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA). Now, in adults 30-79 years ...

As new scientifically grounded evidence is developed and validated, clinical, scientific, and policy experts representing key stakeholders gather every several years to review and revise the ...

The American College of Cardiology (ACC), the American Heart Association (AHA), and nine other leading medical organizations recently released the new guidelines for treating and managing dyslipidemia ...

WASHINGTON — New and aggressive preventative screening guidance aims to identify and treat cholesterol risks well before it could lead to heart disease. The new guidance was released Friday by the ...

A greater reduction LDL-C was seen for combo therapy; reductions also seen in all-cause mortality, major adverse CV events, stroke incidence. HealthDay News — Combination lipid-lowering therapy (LLT) ...

The joint document, published simultaneously in the journals JACC and Circulation, addresses not just cholesterol, but a full range of blood lipids that contribute to atherosclerosis — the buildup of ...

"With this new assessment tool, we can better estimate cardiovascular risk using health information already obtained during an annual physical—cholesterol, blood pressure readings and other personal ...

The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the management of dyslipidemia-abnormal ...